Altimmune Inc (ALT)
8.01
-0.89
(-10.00%)
USD |
NASDAQ |
May 17, 16:00
8.01
0.00 (0.00%)
After-Hours: 20:00
Altimmune Price to Book Value: 3.284 for May 17, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 3.284 |
| May 16, 2024 | 3.649 |
| May 15, 2024 | 3.637 |
| May 14, 2024 | 3.206 |
| May 13, 2024 | 3.022 |
| May 10, 2024 | 2.960 |
| May 09, 2024 | 3.165 |
| May 08, 2024 | 2.936 |
| May 07, 2024 | 2.981 |
| May 06, 2024 | 3.018 |
| May 03, 2024 | 2.993 |
| May 02, 2024 | 2.948 |
| May 01, 2024 | 2.898 |
| April 30, 2024 | 2.685 |
| April 29, 2024 | 2.622 |
| April 26, 2024 | 2.976 |
| April 25, 2024 | 2.952 |
| April 24, 2024 | 2.903 |
| April 23, 2024 | 3.104 |
| April 22, 2024 | 3.062 |
| April 19, 2024 | 2.833 |
| April 18, 2024 | 2.825 |
| April 17, 2024 | 2.886 |
| April 16, 2024 | 3.083 |
| April 15, 2024 | 3.095 |
| Date | Value |
|---|---|
| April 12, 2024 | 3.276 |
| April 11, 2024 | 3.444 |
| April 10, 2024 | 3.284 |
| April 09, 2024 | 3.444 |
| April 08, 2024 | 3.530 |
| April 05, 2024 | 3.727 |
| April 04, 2024 | 3.649 |
| April 03, 2024 | 3.809 |
| April 02, 2024 | 3.835 |
| April 01, 2024 | 4.194 |
| March 31, 2024 | |
| March 28, 2024 | 3.718 |
| March 27, 2024 | 3.247 |
| March 26, 2024 | 3.159 |
| March 25, 2024 | 3.116 |
| March 22, 2024 | 3.316 |
| March 21, 2024 | 3.317 |
| March 20, 2024 | 3.401 |
| March 19, 2024 | 3.182 |
| March 18, 2024 | 3.306 |
| March 15, 2024 | 3.590 |
| March 14, 2024 | 3.650 |
| March 13, 2024 | 3.973 |
| March 12, 2024 | 3.958 |
| March 11, 2024 | 3.594 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4752
Minimum
Nov 19 2019
13.39
Maximum
Jul 20 2020
2.249
Average
1.931
Median
Apr 23 2021
Price to Book Value Benchmarks
| Eli Lilly and Co | 57.12 |
| Amgen Inc | 33.38 |
| Pfizer Inc | 1.759 |
| Viking Therapeutics Inc | 7.911 |
| GlycoMimetics Inc | 0.6676 |
Price to Book Value Related Metrics
| PS Ratio | 1141.07 |
| Price | 8.01 |
| Earnings Yield | -20.10% |
| Market Cap | 567.93M |